ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE
The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Thus,...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FYFE, MATTHEW COLIN THOR ORTEGA MUNOZ, ALBERTO ESTIARTE-MARTINEZ, MARIA DE LOS ANGELES MARTINELL PEDEMONTE, MARC TIRAPU FERNANDEZ DE LA CUESTA, INIGO |
| description | The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Thus, in one specific aspect the invention relates to formulas (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
L'invention concerne des composés (hétéro)aryl cyclopropylamine, comprenant en particulier les composés de formule (I) tel que décrits et définis présentement, et leur utilisation en thérapie, comprenant par exemple, le traitement ou la prévention du cancer, d'une maladie ou d'un état neurologique ou d'une infection virale. Ainsi, dans un aspect spécifique, l'invention concerne les formules (II), (III), (IV), (V), (VI), (VII), (VIII), (IX). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2806008C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2806008C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2806008C3</originalsourceid><addsrcrecordid>eNqFyr8KwjAQgPEuDqI-g_cCQlSQrtfLlRzkT0nikKkUiZNoob4_Org7ffDjWzcBY7FUyIYhhqFYdOIZOkysQbPjbL6WGMQb6SSHmCD0YJM-AnoN2bBEcKyF0MI18bZZ3afHUne_bpp9z5nMoc6vsS7zdKvP-h4JT626KNXS-f_xAaCALdE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE</title><source>esp@cenet</source><creator>FYFE, MATTHEW COLIN THOR ; ORTEGA MUNOZ, ALBERTO ; ESTIARTE-MARTINEZ, MARIA DE LOS ANGELES ; MARTINELL PEDEMONTE, MARC ; TIRAPU FERNANDEZ DE LA CUESTA, INIGO</creator><creatorcontrib>FYFE, MATTHEW COLIN THOR ; ORTEGA MUNOZ, ALBERTO ; ESTIARTE-MARTINEZ, MARIA DE LOS ANGELES ; MARTINELL PEDEMONTE, MARC ; TIRAPU FERNANDEZ DE LA CUESTA, INIGO</creatorcontrib><description>The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Thus, in one specific aspect the invention relates to formulas (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
L'invention concerne des composés (hétéro)aryl cyclopropylamine, comprenant en particulier les composés de formule (I) tel que décrits et définis présentement, et leur utilisation en thérapie, comprenant par exemple, le traitement ou la prévention du cancer, d'une maladie ou d'un état neurologique ou d'une infection virale. Ainsi, dans un aspect spécifique, l'invention concerne les formules (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190709&DB=EPODOC&CC=CA&NR=2806008C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190709&DB=EPODOC&CC=CA&NR=2806008C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FYFE, MATTHEW COLIN THOR</creatorcontrib><creatorcontrib>ORTEGA MUNOZ, ALBERTO</creatorcontrib><creatorcontrib>ESTIARTE-MARTINEZ, MARIA DE LOS ANGELES</creatorcontrib><creatorcontrib>MARTINELL PEDEMONTE, MARC</creatorcontrib><creatorcontrib>TIRAPU FERNANDEZ DE LA CUESTA, INIGO</creatorcontrib><title>ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE</title><description>The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Thus, in one specific aspect the invention relates to formulas (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
L'invention concerne des composés (hétéro)aryl cyclopropylamine, comprenant en particulier les composés de formule (I) tel que décrits et définis présentement, et leur utilisation en thérapie, comprenant par exemple, le traitement ou la prévention du cancer, d'une maladie ou d'un état neurologique ou d'une infection virale. Ainsi, dans un aspect spécifique, l'invention concerne les formules (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyr8KwjAQgPEuDqI-g_cCQlSQrtfLlRzkT0nikKkUiZNoob4_Org7ffDjWzcBY7FUyIYhhqFYdOIZOkysQbPjbL6WGMQb6SSHmCD0YJM-AnoN2bBEcKyF0MI18bZZ3afHUne_bpp9z5nMoc6vsS7zdKvP-h4JT626KNXS-f_xAaCALdE</recordid><startdate>20190709</startdate><enddate>20190709</enddate><creator>FYFE, MATTHEW COLIN THOR</creator><creator>ORTEGA MUNOZ, ALBERTO</creator><creator>ESTIARTE-MARTINEZ, MARIA DE LOS ANGELES</creator><creator>MARTINELL PEDEMONTE, MARC</creator><creator>TIRAPU FERNANDEZ DE LA CUESTA, INIGO</creator><scope>EVB</scope></search><sort><creationdate>20190709</creationdate><title>ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE</title><author>FYFE, MATTHEW COLIN THOR ; ORTEGA MUNOZ, ALBERTO ; ESTIARTE-MARTINEZ, MARIA DE LOS ANGELES ; MARTINELL PEDEMONTE, MARC ; TIRAPU FERNANDEZ DE LA CUESTA, INIGO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2806008C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>FYFE, MATTHEW COLIN THOR</creatorcontrib><creatorcontrib>ORTEGA MUNOZ, ALBERTO</creatorcontrib><creatorcontrib>ESTIARTE-MARTINEZ, MARIA DE LOS ANGELES</creatorcontrib><creatorcontrib>MARTINELL PEDEMONTE, MARC</creatorcontrib><creatorcontrib>TIRAPU FERNANDEZ DE LA CUESTA, INIGO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FYFE, MATTHEW COLIN THOR</au><au>ORTEGA MUNOZ, ALBERTO</au><au>ESTIARTE-MARTINEZ, MARIA DE LOS ANGELES</au><au>MARTINELL PEDEMONTE, MARC</au><au>TIRAPU FERNANDEZ DE LA CUESTA, INIGO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE</title><date>2019-07-09</date><risdate>2019</risdate><abstract>The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Thus, in one specific aspect the invention relates to formulas (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).
L'invention concerne des composés (hétéro)aryl cyclopropylamine, comprenant en particulier les composés de formule (I) tel que décrits et définis présentement, et leur utilisation en thérapie, comprenant par exemple, le traitement ou la prévention du cancer, d'une maladie ou d'un état neurologique ou d'une infection virale. Ainsi, dans un aspect spécifique, l'invention concerne les formules (II), (III), (IV), (V), (VI), (VII), (VIII), (IX).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2806008C |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T03%3A55%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FYFE,%20MATTHEW%20COLIN%20THOR&rft.date=2019-07-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2806008C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |